Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
/in Dendritic Cells, HIV/AIDS, International Publications /von 2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-53Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells
/in Dendritic Cells, HIV/AIDS, International Publications /von 2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-9HIV immunotherapy comes of age: implications for prevention, treatment and cure
/in Dendritic Cells, HIV/AIDS, International Publications /von 2015-12-02 / Expert Rev Clin Immunol 2016;12(2):91-4Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity
/in Dendritic Cells, HIV/AIDS, International Publications /von 2015-03-27 / PLoS Pathog. 2015 Mar;11(3):e1004752Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
/in Dendritic Cells, HIV/AIDS, International Publications /von 2011-07-23 / Vaccine 2011 Sep;29(38):6454-63Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
/in Dendritic Cells, HIV/AIDS, International Publications /von 2009-06-15 / J. Infect. Dis. 2009 Jun;199(12):1862-71In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection
/in HIV/AIDS, International Publications /von 2009-01-23 / PLoS ONE 2009;4(1):e4256Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection
/in HIV/AIDS, International Publications /von 2008-11-26 / Clin. Vaccine Immunol. 2009 Feb;16(2):233-40Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
/in HIV/AIDS, International Publications /von 2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-41IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de